Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Pharmacol Res. 2012 Dec 21;70(1):13–19. doi: 10.1016/j.phrs.2012.12.003

Figure 1.

Figure 1

LCPUFAs can modulate inflammation through several pathways. These pathways include agonism or antagonism of receptors such as TLRs, GPR120, and PPARγ as well as providing substrate for the production of pro-resolution lipid metabolites.